Plain-English translation of NCT07223502 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether finerenone, a medication that helps protect the kidneys, works better when combined with a water pill, compared to a newer two-in-one tablet that combines two different water pills. The study includes people with chronic kidney disease and high blood pressure who have protein in their urine.
People with kidney disease and high blood pressure are at serious risk of their kidneys getting worse over time. Researchers want to find the best combination of medications to slow this decline and protect kidney function.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to take either the new two-in-one tablet once daily, or to continue your current medications (finerenone plus a water pill). The study will monitor your blood pressure, kidney function, and protein levels in your urine through regular clinic visits and blood tests. The exact duration of participation is not specified in the trial details, but you will need to complete all study visits and provide written consent to participate.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
United States